Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp.?

Aphria Inc. has been soaring since its graduation to the TSX last month. The company now has a $1.1 billion market cap and could pass Canopy Growth Corp. with its $1.74 billion market cap over the next few months. There’s no question Canopy stock has slowed down when compared to its peers like Aphria and Aurora Cannabis Inc

The post Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp.? appeared first on Marijuana Industry News.

ChineseInvestors.com, Inc. (CIIX) Eyes Germany’s Growing Medical Hemp Market

ChineseInvestors.com, Inc. (OTCQB: CIIX) attended the ‘Invest 2017’ exhibition in Stuttgart, Germany, on April 7-8, 2017, anticipating that the conference would be an opportunity for CIIX to introduce its hemp companies and products to German investors, but CIIX is not alone in seeing the growth opportunities for medical cannabis in that market.

Washington Times Reports Bipartisan Bill would reclassify Marijuana as Schedule 3 Substance

Saturday, April 8, 2017

Bipartisan legislation proposed in the House on Thursday would make marijuana a Schedule 3 drug, removing cannabis from its current standing as a Schedule 1 substance alongside deadly contraband including ecstasy and heroin. 

By reclassifying weed in the same category as anabolic steroids, Congress would “make it easier for ill-patients and scientific and medical researchers to obtain marijuana,” the bill’s authors said in a statement Thursday.